News
September 7, 2022

Regenstrief and IU developing one of first population-based surveillance systems for long COVID to determine prevalence, trends and outcomes

Shaun Grannis and Brian Dixon

Program is supported by $9 million CDC grant

Post COVID-19 conditions are common but estimates of their prevalence vary widely. Research scientists from Regenstrief Institute and Indiana University’s schools of medicine and public health have received a five-year grant expected to total $9 million from the U.S. Centers for Disease Control and Prevention (CDC) to enhance surveillance and detect trends related to lingering symptoms of COVID-19, known as long COVID-19. In collaboration with the CDC, clinical and public health partners, they will develop one of the first comprehensive, population-based surveillance systems for long COVID in the U.S.

To accomplish this mammoth task, they will utilize the unparalleled public health informatics and surveillance structure of the Indiana Network for Patient Care (INPC) and the Regenstrief Notifiable Condition Detector. Mining data from electronic health records (EHRs) statewide will enable more precise, data-driven estimation of the incidence and prevalence of persistent COVID-19 symptoms as well as measurement of the burden and outcomes on populations affected by long COVID.

The INPC is managed by the Indiana Health Information Exchange and is one of the largest health information exchanges in the nation. Regenstrief created the INPC and provides access to data for research purposes.

Complementing the data mining from existing data, they will also enroll children, adolescents and adults into the study to track the disease course of recent infections to gain an accurate reading of the burden and outcomes of individuals who have survived the virus.

“Long COVID conditions include a wide range of serious health consequences that occur more than four weeks after initial viral infection. Clinicians seek to know more about them and what to expect when patients show up with them for treatment,” said Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S. “Anecdotal information about long COVID abounds, but what we need is accurate, comprehensive scientific evidence. Our study will provide critical information for public health, patients and the clinicians who care for people with long COVID.” Dr. Grannis also is a professor of family medicine at Indiana University School of Medicine.

Leveraging Indiana’s robust health information infrastructure and work with COVID-19 patient cohorts, the grant also supports the training of junior scientists who will be part of a future public health workforce with skills in public health informatics as well as data science. This will complement broader efforts at Regenstrief and IU Fairbanks School of Public Health to educate the public health workforce.

“We believe that the data will help us identify the most affected groups and geographic regions with higher disease burden, discern where health disparities exist and highlight potential barriers to care,” said Regenstrief Institute Center for Biomedical Informatics Interim Director Brian Dixon, PhD, MHA. “What we learn from Indiana will hopefully lead to innovative approaches for monitoring and treating post-covid conditions nationally.” Dr. Dixon also is a professor of epidemiology at the Fairbanks School of Public Health.

In addition to Drs. Grannis and Dixon, who are the principal investigators of the CDC grant, Regenstrief research scientists David Haggstrom, M.D., MAS; Babar Khan, M.D., M.S., and Colin Rogerson, M.D., MPH; and others will collaborate on the “Advancing the epidemiology and management of post-COVID 19 conditions through surveillance and research” project. Ashley Wiensch, MPH, PMP, manager of Regenstrief’s Public Health Informatics Program, will coordinate study logistics.

About Shaun Grannis, M.D., M.S.

In addition to his role as the vice president for data and analytics at Regenstrief Institute, Shaun Grannis, M.D., M.S., is the Regenstrief Professor of Medical Informatics and a professor of family medicine at Indiana University School of Medicine.

About Brian E. Dixon, PhD, MPA

In addition to his roles as interim director of the Regenstrief Institute’s Clem McDonald Center for Biomedical Informatics and director of public health informatics for Regenstrief Institute and Indiana University Richard M. Fairbanks School of Public Health, Brian E. Dixon, PhD, MPA is a professor of epidemiology at the Fairbanks School of Public Health. He is also an affiliate scientist at the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About IU School of Medicine

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

About the Richard M. Fairbanks School of Public Health

Located on the IUPUI and Fort Wayne campuses, the Richard M. Fairbanks School of Public Health is committed to advancing the public’s health and well-being through education, innovation and leadership. The Fairbanks School of Public Health is known for its expertise in biostatistics, epidemiology, cancer research, community health, environmental public health, global health, health policy and health services administration.

Related News

image of pregnant woman with vaccine acting as protection from COVID virus

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two

Thomas Imperiale

Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., discusses the questions that will be investigated in

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental